Bridgewater Associates (Ray Dalio) — UTHR Trade History

Quarter-by-quarter changes in the UNITED THERAPEUTICS CORP DEL position · CUSIP 91307C102
Currently held · 4.3 YearsFirst seen: 2016 Q3
QuarterFiledActivitySharesΔ SharesΔ %Value% Port.
2026 Q22026-08-14Add111,326157+0.1%$60.3M0.25%
2026 Q12026-05-15Add111,16946,574+72.1%$65.9M0.29%
2025 Q42026-02-13Add64,59548,530+302.1%$31.5M0.12%
2025 Q32025-11-13Reduce16,065-179,053-91.8%$6.7M0.03%
2025 Q22025-08-13Add195,1181,334+0.7%$56.1M0.23%
2025 Q12025-05-14Add193,78486,054+79.9%$59.7M0.28%
2024 Q42025-02-13Add107,73045,975+74.4%$38.0M0.17%
2024 Q32024-11-13Add61,75549,003+384.3%$22.1M0.13%
2024 Q22024-08-14Add12,7524,802+60.4%$4.1M0.02%
2024 Q12024-05-14Reduce7,950-1,069-11.9%$1.8M0.01%
2023 Q42024-02-14Reduce9,019-9,128-50.3%$2.0M0.01%
2023 Q32023-11-13Reduce18,147-22,658-55.5%$4.1M0.03%
2023 Q22023-08-11Reduce40,805-460-1.1%$9.0M0.06%
2023 Q12023-05-12Add41,26516,161+64.4%$9.2M0.06%
2022 Q42023-02-13Reduce25,104-19,113-43.2%$7.0M0.04%
2022 Q32022-11-10Reduce44,217-10,209-18.8%$9.3M0.05%
2022 Q22022-08-11New54,42654,426$12.8M0.05%
2022 Q12022-05-13
2021 Q42022-02-14
2021 Q32021-11-12
2021 Q22021-08-13
2021 Q12021-05-14
2020 Q42021-02-12
2020 Q32020-11-13
2020 Q22020-08-12
2020 Q12020-05-14
2019 Q42020-02-13
2019 Q32019-11-13
2019 Q22019-08-13Sold out-9,124-100.0%
2019 Q12019-05-14New9,1249,124$1.1M0.01%
2018 Q42019-02-13Sold out-53,726-100.0%
2018 Q32018-11-13New53,72653,726$6.9M0.07%
2018 Q12018-08-13Sold out-45,325-100.0%
2018 Q22018-08-13Reduce45,325-48,398-51.6%$5.1M0.05%
2017 Q42018-02-13Add93,723953+1.0%$13.9M0.11%
2017 Q32017-11-13Add92,77018,802+25.4%$10.9M0.07%
2017 Q22017-08-10Add73,96815,876+27.3%$9.6M0.09%
2017 Q12017-05-11Add58,09214,187+32.3%$7.9M0.09%
2016 Q42017-02-10Reduce43,905-69,900-61.4%$6.3M0.06%
2016 Q32016-11-09New113,805113,805$13.4M0.13%

Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.